Roman Butler Fullerton & CO Amgen Inc Transaction History

Roman Butler Fullerton & CO

$334 Million
Q3 2024

A detailed history of Roman Butler Fullerton & CO transactions in Amgen Inc stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 2,111 shares of AMGN stock, worth $555,572. This represents 0.2% of its overall portfolio holdings.

Number of Shares

2,111

Previous 2,230 5.34%

Holding current value

$555,572

Previous $696,000 2.3%

% of portfolio

0.2%

Previous 0.24%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$309.38 - $337.38 $36,816 - $40,148	-119 Reduced 5.34%	2,111 $680,000
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $135,579 - $164,763	-516 Reduced 18.79%	2,230 $696,000
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $140,619 - $169,744	523 Added 23.53%	2,746 $780,000
Q4 2023 Jan 31, 2024	BUY	$255.7 - $288.46 $4,602 - $5,192	18 Added 0.82%	2,223 $640,000
Q3 2023 Oct 18, 2023	BUY	$218.65 - $271.46 $23,176 - $28,774	106 Added 5.05%	2,205 $592,000
Q2 2023 Jul 25, 2023	BUY	$214.27 - $253.37 $3,428 - $4,053	16 Added 0.77%	2,099 $466,000
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $3,386 - $4,128	15 Added 0.73%	2,083 $503,000
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $1,603 - $2,037	-7 Reduced 0.34%	2,068 $0
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $2,917 - $3,290	13 Added 0.63%	2,075 $509,000
Q2 2022 Jul 26, 2022	BUY	$230.71 - $256.74 $2,999 - $3,337	13 Added 0.63%	2,062 $513,000
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $2,850 - $3,153	13 Added 0.64%	2,049 $496,000
Q4 2021 Jan 24, 2022	BUY	$198.88 - $227.6 $2,784 - $3,186	14 Added 0.69%	2,036 $458,000
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $2,547 - $2,984	12 Added 0.6%	2,022 $411,000
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $4,671 - $5,182	-20 Reduced 0.99%	2,010 $490,000
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $11,900 - $14,171	55 Added 2.78%	2,030 $467,000
Q3 2020 Oct 15, 2020	BUY	$234.65 - $260.95 $2,111 - $2,348	9 Added 0.46%	1,975 $502,000
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $470,589 - $577,478	-2,379 Reduced 54.75%	1,966 $464,000
Q1 2020 Apr 13, 2020	SELL	$182.24 - $241.7 $217,959 - $289,073	-1,196 Reduced 21.58%	4,345 $881,000
Q4 2019 Jan 27, 2020	BUY	$189.21 - $243.2 $2,648 - $3,404	14 Added 0.25%	5,541 $1.34 Million
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $80,961 - $97,008	-465 Reduced 7.76%	5,527 $1.07 Million
Q2 2019 Jul 22, 2019	BUY	$166.7 - $195.41 $258,384 - $302,885	1,550 Added 34.89%	5,992 $1.1 Million
Q1 2019 Apr 24, 2019	BUY	$180.87 - $203.88 $147,409 - $166,162	815 Added 22.47%	4,442 $844,000
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $647,056 - $755,322	3,627 New	3,627 $735,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.

Account

Roman Butler Fullerton & CO Amgen Inc Transaction History